{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:45:23Z","timestamp":1760240723732,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish 341 Ministerio de Econom\u00eda y Competitividad","award":["AGL2014-52395-C2-1-R and AGL2017-84097-C2-1-R"],"award-info":[{"award-number":["AGL2014-52395-C2-1-R and AGL2017-84097-C2-1-R"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The objective of this study is to evaluate the risk of clinical infections by herpesviruses in patients exposed to valproic acid (VPA). We performed a case-control study nested in a primary cohort selected from the Spanish primary care population-based research database BIFAP (Base de datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria) over the period 2001\u20132015. The events of interest were those diseases caused by any herpesviruses known to infect humans. For each case, up to 10 controls per case matched by age, gender, and calendar date were randomly selected. A conditional logistic regression was used to compute adjusted odds ratios (OR) and their 95% confidence intervals (95% CI). Current use of VPA was associated with a trend towards a reduced risk of clinical infections by herpesviruses as compared with non-users (OR 0.84; CI 95% 0.7\u20131.0; p = 0.057). Among current users, a trend to a decreased risk with treatment durations longer than 90 days was also observed. The results show a trend to a reduced risk of clinical infection by herpesviruses in patients exposed to VPA. These results are consistent with those in vitro studies showing that, in cultured cells, VPA can inhibit the production of the infectious progeny of herpesviruses. This study also shows the efficient use of electronic healthcare records for clinical exploratory research studies.<\/jats:p>","DOI":"10.3390\/jcm8091442","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T11:26:34Z","timestamp":1568201194000},"page":"1442","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Infections by Herpesviruses in Patients Treated with Valproic Acid: A Nested Case-Control Study in the Spanish Primary Care Database, BIFAP"],"prefix":"10.3390","volume":"8","author":[{"given":"Miguel","family":"Gil","sequence":"first","affiliation":[{"name":"BIFAP, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), 28022 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-8516","authenticated-orcid":false,"given":"Roc\u00edo","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"BIFAP, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), 28022 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"V\u00e1zquez-Calvo","sequence":"additional","affiliation":[{"name":"Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM), Nicol\u00e1s Cabrera 1, 28049 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"\u00c1lvarez-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"BIFAP, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), 28022 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6015-3613","authenticated-orcid":false,"given":"Miguel A.","family":"Mart\u00edn-Acebes","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Instituto Nacional de Investigaci\u00f3n y Tecnolog\u00eda Agraria y Alimentaria (INA), 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4628-7575","authenticated-orcid":false,"given":"Beatriz","family":"Praena","sequence":"additional","affiliation":[{"name":"Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM), Nicol\u00e1s Cabrera 1, 28049 Madrid, Spain"},{"name":"Universidad Aut\u00f3noma de Madrid, Departamento de Biolog\u00eda Molecular, Edificio de. Biolog\u00eda, Darwin 2, Cantoblanco, 28049 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Bello-Morales","sequence":"additional","affiliation":[{"name":"Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM), Nicol\u00e1s Cabrera 1, 28049 Madrid, Spain"},{"name":"Universidad Aut\u00f3noma de Madrid, Departamento de Biolog\u00eda Molecular, Edificio de. Biolog\u00eda, Darwin 2, Cantoblanco, 28049 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-5544","authenticated-orcid":false,"given":"Juan-Carlos","family":"Saiz","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Instituto Nacional de Investigaci\u00f3n y Tecnolog\u00eda Agraria y Alimentaria (INA), 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"L\u00f3pez-Guerrero","sequence":"additional","affiliation":[{"name":"Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM), Nicol\u00e1s Cabrera 1, 28049 Madrid, Spain"},{"name":"Universidad Aut\u00f3noma de Madrid, Departamento de Biolog\u00eda Molecular, Edificio de. Biolog\u00eda, Darwin 2, Cantoblanco, 28049 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Tabar\u00e9s","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Madrid, Facultad de Medicina, Arzobispo Morcillo 4, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Sobrino","sequence":"additional","affiliation":[{"name":"Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM), Nicol\u00e1s Cabrera 1, 28049 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00392-016-1025-6","article-title":"Electronic health records to facilitate clinical research","volume":"106","author":"Cowie","year":"2017","journal-title":"Clin. Res. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: A simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.01717-10","article-title":"and Mart\u00edn-Acebes, M.A. Inhibition of enveloped virus infection of cultured cells by valproic acid","volume":"85","author":"Saiz","year":"2011","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2016.01.009","article-title":"Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid","volume":"214","author":"Crespillo","year":"2016","journal-title":"Virus. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lee, K., Vivithanaporn, P., Siemieniuk, R.A., Krentz, H.B., Maingat, F., Gill, M.J., and Power, C. (2010). Outcomes and immune benefits of anti-epileptic drug therapy in HIV\/AIDS. BMC Neurology.","DOI":"10.1186\/1471-2377-10-44"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/102453312X13376952196494","article-title":"Valproic acid inhibits proliferation of EB virus-infected natural killer cells","volume":"17","author":"Fujii","year":"2012","journal-title":"Hematology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2016.09.012","article-title":"Mood stabilizers inhibit citomegalovirus infection","volume":"499","author":"Ornaghi","year":"2016","journal-title":"Virology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00002030-200005050-00021","article-title":"Valproic acid induces human herpes virus-8 lytic gene expression in BCBL-1cells","volume":"14","author":"Shaw","year":"2000","journal-title":"AIDS"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.antiviral.2013.05.012","article-title":"Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid","volume":"99","author":"Sobrino","year":"2013","journal-title":"Antiviral. Res."},{"key":"ref_10","unstructured":"BIFAP (2019, August 04). Base de datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria. Available online: www.bifap.org."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1574884708666131111211802","article-title":"Bridging differences in outcomes of pharmacoepidemiological studies: Design and first results of the PROTECT project","volume":"9","author":"Kurz","year":"2014","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: A cross-national descriptive study from the PROTECT-EU Project","volume":"25","author":"Huerta","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pds.3816","article-title":"Hip\/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): A methodological approach to assess consistencies across databases from the PROTECT-EU project","volume":"25","author":"Requena","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pds.4686","article-title":"Validation study of colorectal cancer diagnosis in the Spanish primary care database, BIFAP","volume":"28","author":"Gil","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating Medication Effects Outside of Clinical Trials: New-User Designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(05)67074-2","article-title":"Valproic acid: A potential role in treating latent HIV infection","volume":"366","author":"Routy","year":"2005","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1128\/JVI.02659-10","article-title":"Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-Barr virus lytic cycle","volume":"85","author":"Daigle","year":"2011","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jcv.2009.08.006","article-title":"Early effects of drugs responsible for DRESS on HHV-6 replication in vitro","volume":"46","author":"Mardivirin","year":"2009","journal-title":"J. Clin Virol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1172\/JCI80713","article-title":"Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma","volume":"125","author":"Nakashima","year":"2015","journal-title":"J. Clin Invest."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/mt.2008.155","article-title":"Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses","volume":"16","author":"Otsuki","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1167\/iovs.05-0369","article-title":"Increased Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells by Valproic Acid Depends on Histone Deacetylase Inhibition","volume":"46","author":"Michaelis","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Drug Discov."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1128\/JVI.00723-11","article-title":"Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: Rare resistance is overcome by blocking interferon pathways","volume":"85","author":"Paglino","year":"2011","journal-title":"J. Virol."},{"key":"ref_24","first-page":"559","article-title":"La varicela en Espa\u00f1a: Incidencia y hospitalizaci\u00f3n","volume":"6","author":"Amela","year":"2004","journal-title":"Rev Pediatr Aten Primaria"},{"key":"ref_25","unstructured":"(2019, August 18). Asociacion Espa\u00f1ola Vacunolog\u00eda website. Available online: https:\/\/www.vacunas.org\/vacunacion-frente-a-la-varicela\/."},{"key":"ref_26","unstructured":"(2019, August 04). Pharmacovigilance Risk Assessment Committee (PRAC) Assessment report Referral under Article 31 of Directive 2001\/83\/EC Medicinal products containing substances related to valproate EMA\/198940\/2018. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Valproate_2017_31\/Position_provided_by_CMDh\/WC500250221.pdf."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/9\/1442\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:18:56Z","timestamp":1760188736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/9\/1442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["jcm8091442"],"URL":"https:\/\/doi.org\/10.3390\/jcm8091442","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2019,9,11]]}}}